The role of non-coding RNA in development of pediatric brain tumors
CBTN plasma samples will expand our cohort from Sheba Medical Center to see if we can correlate the comprehensive list of the lincRNA in plasma to the clinical data of the patient.
Previous PostDrivers of recurrence in PFA ependymoma
Next PostPharmaco-proteogenomic profiling of pediatric high-grade gliomas
